Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60.

Dean A RegierBrandon ChanSarah CostaDavid W ScottChristian SteidlJoseph M ConnorsAly KarsanMarco A MarraRobert KridelIan CromwellSamantha Pollard

Published in: Cancers (2022)

We encourage further clinical trials to reduce uncertainty around the implementation of GEP-classified COO personalized treatment in this patient population.

Keyphrases

diffuse large b cell lymphoma
clinical trial
epstein barr virus
end stage renal disease
primary care
randomized controlled trial
case report
peritoneal dialysis
quality improvement
replacement therapy
study protocol